Thursday, 29 September 2005 (Hall B) 14:00-15:30

Oral Session

Endothelial Function / Dysfunction

Chairperson: M. Shechter (Tel Hashomer, IL)

(O205) Nitric oxide limits activation of Rac by thrombin: role in the redox-sensitive regulation of angiogenesis by HIF-1 and PAI-1.

R.S. Belaiba, T. Djordjevic, T. Kietzmann, J. Hess, A. Görlach (München and Kaiserslautern, DE)
(O206) Essential role of medullar high molecular weight FGF2 in the effect of estradiol on reendothelialization - Possible dissociation with EPC mobilization.

V. Fontaine, C. Filipe, N. Werner, P. Gourdy, A. Billon, B. Garmy-Susini, L. Henrik, A. Mugniot, F. Bayard, H. Prats, T. Doetschman, G. Nickenig, J-F. Arnal (Toulouse, FR; Homburg/Saar, DE; Cincinnati, US)
(O207) Reendothelialization capacity and nitric oxide release of endothelial progenitor cells is impaired in patients with type 2 diabetes: effect of rosiglitazone treatment.

S.A. Sorrentino, F.H. Bahlmann, Chr. Besler, M. Müller, S. Schulz, N. Kirchhoff, D. Fliser, H. Drexler, U. Landmesser (Hannover, DE)
(O208) Fractalkine induces vascular dysfunction and reduces nitric oxide bioavailability by NADHP oxidase activation and increased generation of superoxide anions.

A. Schäfer, Chr. Schulz, D. Fraccarollo, P. Tas, G. Ertl, J. Bauersachs (Würzburg and München, DE)
(O209) Different fast food meals acutely impair endothelial function in healthy adults: the Hamburg Burger Trial.

R. Maas, T. Rudolph, K. Ruempler, E. Schwedhelm, J. Tan-Andresen, U. Riederer, R. Böger (Hamburg, DE)
(O210) Activation of 5'-AMP-activated protein kinase induces nitric oxide-dependent vasodilatation and uncovers insulin-mediated vasodilatation of skeletal muscle resistance arteries.

E.C. Eringa, C.D.A. Stehouwer, G.P. van Nieuw Amerongen, P. Sipkema (Amsterdam and Maastricht, NL)